Table 3 Consistently reported down-regulated miRNAs ( n = 28) in profiling studies (lung cancer tissue versus normal)

miR-126

10 (19,21,25,26,27, 28,29,30,31,32)

587

8

311

0.33

0.00 - 0.69

miR-30a

8 (19,21,25,26,27,28,29,31)

339

7

271

0.36

0.04 - 0.61

miR-451

6 (19,21,25,27,28,29)

265

6

265

0.37

0.01 - 0.53

miR-486-5p

5 (19,22,26,27,28)

437

4

369

0.39

0.13 - 0.53

miR-30d

5 (21,25,28,29,31)

154

5

154

0.34

0.08 - 0.57

miR-145

4 (26,28,30,32)

362

2

86

0.23

0.09 - 0.38

miR-143

4 (21,28,30,32)

310

3

102

0.33

0.13 - 0.59

miR-139-5p

3 (22,27,29)

301

3

301

0.55

0.40 - 0.64

miR-126*

3 (21,25,30)

280

2

72

0.33

0.20 - 0.45

miR-140-3p

3 (26,27,28)

179

2

111

0.29

0.17 - 0.42

miR-138

3 (25,26,32)

164

2

96

0.64

0.56 - 0.72

miR-30b

3 (25,28,29)

132

3

132

0.41

0.11 - 0.58

miR-486

3 (25,29,32)

126

3

126

0.44

0.34 - 0.53

miR-101

3 (21,27,31)

87

3

87

0.34

0.24 - 0.48

miR-125a

2 (24,30)

279

0

-

-

-

miR-198

2 (27,30)

273

1

65

0.25

-

miR-144*

2 (22,27)

271

2

271

0.31

0.14 - 0.48

miR-140

2 (30,32)

248

1

40

0.66

-

miR-218

2 (22,32)

246

2

246

0.61

0.60 - 0.62

miR-32

2 (20,30)

220

0

-

-

-

miR-338-3p

2 (26,27)

133

1

65

0.20

-

miR-99a

2 (27,28)

111

2

111

0.31

0.20 - 0.42

miR-195

2 (26,29)

98

1

30

0.53

-

miR-497

2 (26,29)

98

1

30

0.66

-

miR-30c

2 (25,29)

86

2

86

0.58

0.54 - 0.61

miR-130a

2 (21,27)

81

2

81

0.46

0.45 - 0.46

miR-16

2 (28,29)

76

2

76

0.37

0.18 - 0.57

miR-139

2 (29,32)

70

2

70

0.53

0.49 - 0.58